|
ES2200184T7
(es)
|
1996-07-24 |
2015-02-10 |
Warner-Lambert Company Llc |
Isobutilgaba y sus derivados para el tratamiento del dolor
|
|
JP3878809B2
(ja)
|
1997-09-18 |
2007-02-07 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
ガバペンチン類似体を製造するための新規な立体選択的方法
|
|
US6984659B2
(en)
|
1997-11-18 |
2006-01-10 |
Klinikum Der Albert-Ludwigs Universitaet |
2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level
|
|
DE19751062A1
(de)
*
|
1997-11-18 |
1999-07-08 |
Univ Ludwigs Albert |
An 4-Stellung substituierte 2-Pyrrolidinon-Derivate zur Verringerung des extrazellulären Glutamat-Spiegels
|
|
HUP0100069A3
(en)
*
|
1997-12-16 |
2002-04-29 |
Warner Lambert Co |
4(3)substituted-4(3)-aminomethyl-pyran, or -thiopyran-piperidine derivatives, their preparation and their use in the treatment of neurological disorders
|
|
JP2003528148A
(ja)
*
|
2000-03-28 |
2003-09-24 |
デロレンゾ、ロバート・ジェイ |
損傷に際して神経細胞中に形成される新規カルシウム損傷電流の阻害は神経細胞死を抑制する
|
|
EP1361847A2
(en)
|
2000-10-06 |
2003-11-19 |
Xenoport, Inc. |
Bile-acid conjugates for providing sustained systemic concentrations of drugs
|
|
EP1343805A4
(en)
|
2000-10-06 |
2005-07-20 |
Xenoport Inc |
COMPOUNDS DERIVED FROM GALLENIC ACIDS FOR THE PROVISION OF CONTINUING SYSTEMIC CONCENTRATIONS OF MEDICINAL PRODUCTS AFTER ORAL ADMINISTRATION
|
|
GB2368579A
(en)
*
|
2000-10-31 |
2002-05-08 |
Parke Davis & Co Ltd |
Azole pharmaceutical agents
|
|
US7186855B2
(en)
|
2001-06-11 |
2007-03-06 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US8048917B2
(en)
|
2005-04-06 |
2011-11-01 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US7232924B2
(en)
|
2001-06-11 |
2007-06-19 |
Xenoport, Inc. |
Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
|
|
US6818787B2
(en)
|
2001-06-11 |
2004-11-16 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
WO2002100344A2
(en)
|
2001-06-11 |
2002-12-19 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
|
EP1404324B2
(en)
|
2001-06-11 |
2011-04-06 |
XenoPort, Inc. |
Prodrugs of gaba analogs, compositions and uses thereof
|
|
AU2002316231A1
(en)
|
2002-02-19 |
2003-09-29 |
Xenoport, Inc. |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
|
|
AU2003222033A1
(en)
|
2002-03-20 |
2003-10-08 |
Xenoport |
Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof
|
|
AU2003243180A1
(en)
|
2002-05-17 |
2003-12-12 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
|
US20040092498A1
(en)
*
|
2002-08-16 |
2004-05-13 |
David Blakemore |
Substituted glycine derivatives for use as medicaments
|
|
US7060727B2
(en)
|
2002-12-11 |
2006-06-13 |
Xenoport, Inc. |
Prodrugs of fused GABA analogs, pharmaceutical compositions and uses thereof
|
|
CA2451267A1
(en)
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
NZ539972A
(en)
|
2002-12-13 |
2008-05-30 |
Warner Lambert Co |
Alpha-2-delta ligand to treat lower urinary tract symptoms
|
|
CA2537837A1
(en)
|
2003-09-11 |
2005-03-24 |
Xenoport, Inc. |
Treating and/or preventing urinary incontinence using prodrugs of gaba analogs
|
|
EP2156863A3
(en)
|
2003-09-12 |
2011-01-12 |
Pfizer Limited |
Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline reuptake inhibitors
|
|
CA2538802C
(en)
|
2003-09-17 |
2015-01-27 |
Xenoport, Inc. |
Treating or preventing restless legs syndrome using prodrugs of gaba analogs
|
|
PT1677767E
(pt)
|
2003-10-14 |
2011-10-13 |
Xenoport Inc |
Forma cristalina de análogo de ácido gama-aminobutírico
|
|
JP5646126B2
(ja)
|
2003-12-11 |
2014-12-24 |
サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． |
鎮静剤と神経伝達物質調節剤の併用、および睡眠の質の向上方法および鬱の治療方法
|
|
WO2006050514A1
(en)
|
2004-11-04 |
2006-05-11 |
Xenoport, Inc. |
Gabapentin prodrug sustained release oral dosage forms
|
|
PL2125021T3
(pl)
|
2006-12-22 |
2011-10-31 |
Recordati Ireland Ltd |
Leczenie skojarzone zaburzeń w obrębie dolnych dróg moczowych z zastosowaniem ligandów α2δ i przeciwzapalnych leków niesterydowych (NSAIDs)
|
|
BRPI0815673A2
(pt)
*
|
2007-08-23 |
2015-02-18 |
Novartis Ag |
Sulfonas cíclicas substituídas por aminobenzila úteis como inibidores de bace.
|
|
EP2250143B1
(en)
|
2008-01-25 |
2016-04-20 |
XenoPort, Inc. |
Method for the enzymatic kinetic resolution of acyloxyalkyl thiocarbonates used for the synthesis of acyloxyalkyl carbamates
|
|
US7872046B2
(en)
|
2008-01-25 |
2011-01-18 |
Xenoport, Inc. |
Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
|
|
WO2009094577A2
(en)
|
2008-01-25 |
2009-07-30 |
Xenoport, Inc. |
Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
|
|
EP3075722A1
(en)
|
2008-10-08 |
2016-10-05 |
Xgene Pharmaceutical Inc |
Gaba conjugates and methods of use thereof
|
|
WO2010084797A1
(ja)
*
|
2009-01-21 |
2010-07-29 |
第一三共株式会社 |
含ヘテロ原子化合物
|
|
US9066853B2
(en)
|
2013-01-15 |
2015-06-30 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable fiber
|
|
HUE047629T2
(hu)
|
2013-01-28 |
2020-05-28 |
Lopez Hector L |
Eljárások ß-alanin tolerancia, farmakodinamika és hatékonyság javítására és azok alkalmazása
|
|
US20210221768A1
(en)
|
2018-05-14 |
2021-07-22 |
Xgene Pharmaceutical Inc. |
Crystalline forms of 1-(acyloxy)-alkyl carbamate drug conjugates of naproxen and pregabalin
|